1. Home
  2. CNXC vs TLX Comparison

CNXC vs TLX Comparison

Compare CNXC & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concentrix Corporation

CNXC

Concentrix Corporation

HOLD

Current Price

$40.27

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$7.82

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXC
TLX
Founded
1991
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CNXC
TLX
Price
$40.27
$7.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$69.00
$21.00
AVG Volume (30 Days)
1.2M
138.4K
Earning Date
01-14-2026
01-15-2026
Dividend Yield
3.60%
N/A
EPS Growth
54.10
N/A
EPS
4.74
0.04
Revenue
$9,720,870,000.00
$664,225,558.00
Revenue This Year
$4.00
N/A
Revenue Next Year
$3.16
N/A
P/E Ratio
$8.43
$184.10
Revenue Growth
3.40
55.35
52 Week Low
$31.63
$7.72
52 Week High
$66.00
$30.36

Technical Indicators

Market Signals
Indicator
CNXC
TLX
Relative Strength Index (RSI) 61.96 27.12
Support Level $38.40 $7.72
Resistance Level $40.02 $10.03
Average True Range (ATR) 1.27 0.27
MACD 0.61 -0.18
Stochastic Oscillator 88.65 4.55

Price Performance

Historical Comparison
CNXC
TLX

About CNXC Concentrix Corporation

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: